Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lower Extremity | 32 | 2024 | 1202 | 2.810 |
Why?
|
Vascular Surgical Procedures | 32 | 2024 | 1489 | 2.550 |
Why?
|
Ischemia | 26 | 2024 | 1882 | 1.960 |
Why?
|
Peripheral Arterial Disease | 24 | 2024 | 1273 | 1.880 |
Why?
|
Endovascular Procedures | 25 | 2024 | 2183 | 1.800 |
Why?
|
Limb Salvage | 27 | 2024 | 481 | 1.540 |
Why?
|
Peripheral Vascular Diseases | 12 | 2012 | 488 | 1.390 |
Why?
|
Blood Vessel Prosthesis Implantation | 21 | 2020 | 1428 | 1.190 |
Why?
|
Veins | 7 | 2018 | 768 | 1.060 |
Why?
|
Femoral Artery | 9 | 2023 | 826 | 1.040 |
Why?
|
Angioplasty | 12 | 2020 | 355 | 1.040 |
Why?
|
Popliteal Artery | 6 | 2023 | 310 | 0.960 |
Why?
|
Angioplasty, Balloon | 11 | 2018 | 589 | 0.940 |
Why?
|
Vascular Grafting | 4 | 2018 | 162 | 0.890 |
Why?
|
Endarterectomy, Carotid | 9 | 2024 | 555 | 0.850 |
Why?
|
Varicose Veins | 3 | 2013 | 155 | 0.850 |
Why?
|
Aortic Aneurysm, Abdominal | 15 | 2022 | 1228 | 0.840 |
Why?
|
Stents | 22 | 2024 | 3179 | 0.720 |
Why?
|
Carotid Stenosis | 6 | 2024 | 860 | 0.590 |
Why?
|
Vascular Patency | 17 | 2024 | 911 | 0.540 |
Why?
|
Graft Occlusion, Vascular | 6 | 2015 | 537 | 0.530 |
Why?
|
Chi-Square Distribution | 27 | 2018 | 3416 | 0.490 |
Why?
|
Intermittent Claudication | 5 | 2016 | 304 | 0.480 |
Why?
|
Blood Vessel Prosthesis | 9 | 2019 | 952 | 0.460 |
Why?
|
Arterial Occlusive Diseases | 4 | 2012 | 748 | 0.450 |
Why?
|
Education, Medical, Graduate | 2 | 2018 | 2373 | 0.440 |
Why?
|
Diabetes Complications | 5 | 2007 | 1315 | 0.430 |
Why?
|
Leg | 6 | 2013 | 1088 | 0.430 |
Why?
|
Wound Healing | 12 | 2024 | 2805 | 0.420 |
Why?
|
Time Factors | 51 | 2024 | 39967 | 0.420 |
Why?
|
Venous Insufficiency | 1 | 2012 | 108 | 0.380 |
Why?
|
Aortic Rupture | 5 | 2016 | 319 | 0.370 |
Why?
|
Diabetic Foot | 3 | 2010 | 380 | 0.360 |
Why?
|
Treatment Outcome | 63 | 2024 | 64680 | 0.340 |
Why?
|
Saphenous Vein | 4 | 2020 | 516 | 0.330 |
Why?
|
Kidney Failure, Chronic | 5 | 2016 | 2471 | 0.330 |
Why?
|
Quality Indicators, Health Care | 6 | 2016 | 1792 | 0.330 |
Why?
|
Diabetic Angiopathies | 2 | 2005 | 803 | 0.320 |
Why?
|
Risk Factors | 57 | 2024 | 74206 | 0.320 |
Why?
|
Diabetes Mellitus | 9 | 2018 | 5840 | 0.310 |
Why?
|
Creatinine | 4 | 2013 | 1899 | 0.300 |
Why?
|
Retrospective Studies | 56 | 2024 | 80636 | 0.280 |
Why?
|
Inguinal Canal | 2 | 2005 | 71 | 0.280 |
Why?
|
Decision Support Techniques | 4 | 2017 | 1998 | 0.270 |
Why?
|
Arteries | 2 | 2008 | 1123 | 0.270 |
Why?
|
Aged, 80 and over | 43 | 2024 | 58976 | 0.250 |
Why?
|
Carotid Arteries | 4 | 2002 | 941 | 0.250 |
Why?
|
Internship and Residency | 2 | 2018 | 5880 | 0.250 |
Why?
|
Polytetrafluoroethylene | 4 | 2002 | 246 | 0.250 |
Why?
|
Kaplan-Meier Estimate | 13 | 2017 | 6484 | 0.250 |
Why?
|
Aged | 71 | 2024 | 169289 | 0.250 |
Why?
|
Patient Selection | 11 | 2019 | 4244 | 0.240 |
Why?
|
Carotid Artery Diseases | 4 | 2013 | 877 | 0.240 |
Why?
|
Aortic Aneurysm, Thoracic | 4 | 2013 | 696 | 0.230 |
Why?
|
Logistic Models | 22 | 2018 | 13255 | 0.230 |
Why?
|
Wound Infection | 2 | 2017 | 246 | 0.230 |
Why?
|
Risk Assessment | 28 | 2024 | 23995 | 0.230 |
Why?
|
Blood Loss, Surgical | 1 | 2008 | 637 | 0.230 |
Why?
|
Multivariate Analysis | 19 | 2018 | 12059 | 0.230 |
Why?
|
Heart Function Tests | 1 | 2005 | 318 | 0.230 |
Why?
|
Kidney Transplantation | 2 | 2013 | 4234 | 0.230 |
Why?
|
Ultrasonography, Interventional | 4 | 2019 | 1496 | 0.220 |
Why?
|
Fellowships and Scholarships | 1 | 2012 | 1117 | 0.220 |
Why?
|
Ribs | 1 | 2024 | 252 | 0.210 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2024 | 97 | 0.210 |
Why?
|
Prosthesis-Related Infections | 3 | 2016 | 488 | 0.210 |
Why?
|
Carotid Artery, Internal | 2 | 2024 | 445 | 0.200 |
Why?
|
Odds Ratio | 15 | 2018 | 9646 | 0.200 |
Why?
|
Tibial Arteries | 1 | 2002 | 60 | 0.200 |
Why?
|
Postoperative Complications | 19 | 2024 | 15631 | 0.190 |
Why?
|
Male | 78 | 2024 | 360804 | 0.180 |
Why?
|
Middle Aged | 56 | 2024 | 220895 | 0.170 |
Why?
|
Constriction, Pathologic | 3 | 2015 | 1096 | 0.170 |
Why?
|
Female | 78 | 2024 | 392644 | 0.170 |
Why?
|
Humans | 99 | 2024 | 761504 | 0.170 |
Why?
|
Reoperation | 13 | 2018 | 4303 | 0.170 |
Why?
|
Vascular Diseases | 1 | 2008 | 1161 | 0.170 |
Why?
|
Databases, Factual | 9 | 2021 | 7967 | 0.170 |
Why?
|
Quality Improvement | 4 | 2016 | 3801 | 0.170 |
Why?
|
Decompression, Surgical | 1 | 2024 | 607 | 0.160 |
Why?
|
Length of Stay | 14 | 2024 | 6425 | 0.160 |
Why?
|
Groin | 1 | 2019 | 106 | 0.160 |
Why?
|
Lumbar Vertebrae | 1 | 2008 | 1879 | 0.160 |
Why?
|
Spinal Fusion | 1 | 2008 | 1286 | 0.160 |
Why?
|
Tunica Intima | 3 | 1999 | 459 | 0.160 |
Why?
|
Aorta, Abdominal | 2 | 2019 | 625 | 0.160 |
Why?
|
Foot | 3 | 2010 | 575 | 0.150 |
Why?
|
Travel | 1 | 2024 | 796 | 0.150 |
Why?
|
Critical Illness | 6 | 2017 | 2723 | 0.150 |
Why?
|
Surgical Wound Infection | 5 | 2016 | 1527 | 0.150 |
Why?
|
Chronic Disease | 11 | 2024 | 9318 | 0.140 |
Why?
|
Data Collection | 2 | 2016 | 3322 | 0.140 |
Why?
|
Learning Curve | 1 | 2018 | 230 | 0.140 |
Why?
|
Angiography | 2 | 2020 | 1595 | 0.140 |
Why?
|
Aneurysm, Ruptured | 3 | 2012 | 464 | 0.140 |
Why?
|
Proportional Hazards Models | 13 | 2017 | 12463 | 0.140 |
Why?
|
Aorta | 3 | 2022 | 2042 | 0.130 |
Why?
|
Recurrence | 8 | 2024 | 8465 | 0.130 |
Why?
|
Endothelial Growth Factors | 2 | 1999 | 673 | 0.130 |
Why?
|
Anastomosis, Surgical | 3 | 1998 | 983 | 0.130 |
Why?
|
Databases as Topic | 7 | 2011 | 473 | 0.130 |
Why?
|
Retreatment | 2 | 2016 | 598 | 0.130 |
Why?
|
Catheterization, Peripheral | 1 | 2019 | 343 | 0.120 |
Why?
|
Boston | 11 | 2017 | 9326 | 0.120 |
Why?
|
Endoleak | 1 | 2016 | 111 | 0.120 |
Why?
|
Lymphokines | 2 | 1999 | 927 | 0.120 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 1996 | 277 | 0.120 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2001 | 1241 | 0.120 |
Why?
|
Celiac Artery | 1 | 2015 | 65 | 0.120 |
Why?
|
Myocardial Infarction | 6 | 2018 | 11460 | 0.120 |
Why?
|
Silver Compounds | 1 | 2014 | 23 | 0.120 |
Why?
|
Nerve Block | 1 | 2021 | 706 | 0.110 |
Why?
|
Cyclins | 1 | 1996 | 594 | 0.110 |
Why?
|
Anesthesia, General | 1 | 2021 | 1174 | 0.110 |
Why?
|
Meglumine | 1 | 2014 | 144 | 0.110 |
Why?
|
Treatment Failure | 4 | 2019 | 2645 | 0.110 |
Why?
|
Voluntary Health Agencies | 1 | 2013 | 38 | 0.110 |
Why?
|
Benchmarking | 1 | 2020 | 1045 | 0.110 |
Why?
|
Muscle, Smooth, Vascular | 2 | 1999 | 1493 | 0.110 |
Why?
|
Stockings, Compression | 1 | 2012 | 36 | 0.110 |
Why?
|
Alginates | 1 | 2014 | 248 | 0.110 |
Why?
|
Renal Dialysis | 3 | 2015 | 1797 | 0.110 |
Why?
|
Aortic Diseases | 1 | 2019 | 735 | 0.110 |
Why?
|
Perioperative Care | 1 | 2001 | 1033 | 0.110 |
Why?
|
Bandages | 1 | 2014 | 269 | 0.100 |
Why?
|
Polyesters | 1 | 2014 | 373 | 0.100 |
Why?
|
Aorta, Thoracic | 1 | 2019 | 1096 | 0.100 |
Why?
|
Death, Sudden, Cardiac | 1 | 2001 | 1555 | 0.100 |
Why?
|
Infectious Mononucleosis | 1 | 2012 | 133 | 0.100 |
Why?
|
Cerebrovascular Disorders | 1 | 1999 | 1474 | 0.100 |
Why?
|
Renal Artery Obstruction | 1 | 2013 | 219 | 0.100 |
Why?
|
Anti-Infective Agents, Local | 1 | 2014 | 247 | 0.100 |
Why?
|
Autoantigens | 1 | 1996 | 891 | 0.100 |
Why?
|
Polyethylenes | 1 | 2014 | 290 | 0.100 |
Why?
|
Registries | 9 | 2018 | 8224 | 0.100 |
Why?
|
Sclerotherapy | 1 | 2012 | 182 | 0.100 |
Why?
|
Stroke | 8 | 2018 | 9757 | 0.100 |
Why?
|
Health Status Disparities | 2 | 2013 | 1852 | 0.090 |
Why?
|
Occupational Health | 1 | 2017 | 806 | 0.090 |
Why?
|
Anti-Bacterial Agents | 1 | 2009 | 7407 | 0.090 |
Why?
|
Genes | 1 | 1995 | 1823 | 0.090 |
Why?
|
Lung Diseases | 1 | 2021 | 1909 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2021 | 1739 | 0.090 |
Why?
|
Organometallic Compounds | 1 | 2014 | 647 | 0.090 |
Why?
|
Staphylococcal Infections | 2 | 2013 | 1408 | 0.090 |
Why?
|
Research Design | 2 | 2016 | 6180 | 0.090 |
Why?
|
Radiography, Interventional | 1 | 2017 | 1121 | 0.090 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 15266 | 0.090 |
Why?
|
Myocardial Ischemia | 1 | 2001 | 2113 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 1924 | 0.090 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2022 | 2243 | 0.090 |
Why?
|
Viscera | 1 | 2010 | 138 | 0.080 |
Why?
|
Resistin | 1 | 2010 | 172 | 0.080 |
Why?
|
Surgical Procedures, Operative | 1 | 2001 | 1922 | 0.080 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 1996 | 1516 | 0.080 |
Why?
|
Radiation Dosage | 1 | 2017 | 1958 | 0.080 |
Why?
|
Survival Rate | 8 | 2013 | 12725 | 0.080 |
Why?
|
Hypoglycemic Agents | 2 | 2018 | 3085 | 0.080 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 2009 | 92 | 0.080 |
Why?
|
Dogs | 4 | 1998 | 3839 | 0.080 |
Why?
|
Renal Artery | 1 | 2010 | 351 | 0.080 |
Why?
|
Hemostasis, Surgical | 1 | 2008 | 126 | 0.070 |
Why?
|
International Classification of Diseases | 1 | 2013 | 909 | 0.070 |
Why?
|
Healthcare Disparities | 2 | 2013 | 3358 | 0.070 |
Why?
|
United States | 19 | 2018 | 72334 | 0.070 |
Why?
|
Occupational Exposure | 1 | 2017 | 1813 | 0.070 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2014 | 1050 | 0.070 |
Why?
|
Insulin | 2 | 2018 | 6596 | 0.070 |
Why?
|
RNA, Messenger | 4 | 1998 | 12795 | 0.070 |
Why?
|
Blotting, Northern | 3 | 1998 | 1545 | 0.070 |
Why?
|
Severity of Illness Index | 7 | 2020 | 15842 | 0.070 |
Why?
|
Hyperplasia | 4 | 1999 | 1152 | 0.070 |
Why?
|
Body Mass Index | 4 | 2017 | 12953 | 0.070 |
Why?
|
Gene Expression | 2 | 1998 | 7581 | 0.070 |
Why?
|
Patient Admission | 1 | 2013 | 1367 | 0.060 |
Why?
|
Glucose Tolerance Test | 1 | 2009 | 1178 | 0.060 |
Why?
|
Thinness | 1 | 2009 | 490 | 0.060 |
Why?
|
Adult | 17 | 2024 | 221177 | 0.060 |
Why?
|
E2F Transcription Factors | 1 | 2006 | 269 | 0.060 |
Why?
|
Punctures | 2 | 2019 | 366 | 0.060 |
Why?
|
Neurology | 1 | 2013 | 780 | 0.060 |
Why?
|
Curriculum | 1 | 2018 | 3743 | 0.060 |
Why?
|
Glomerular Filtration Rate | 1 | 2013 | 2176 | 0.060 |
Why?
|
Quality of Life | 2 | 2016 | 13367 | 0.060 |
Why?
|
Subclavian Vein | 1 | 2024 | 57 | 0.060 |
Why?
|
Clinical Competence | 2 | 2018 | 4792 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2015 | 2091 | 0.060 |
Why?
|
Adiponectin | 1 | 2010 | 1113 | 0.060 |
Why?
|
Blood Glucose | 1 | 2018 | 6391 | 0.060 |
Why?
|
Proteinuria | 1 | 2006 | 607 | 0.060 |
Why?
|
Patient Readmission | 2 | 2018 | 3270 | 0.060 |
Why?
|
Comorbidity | 6 | 2018 | 10508 | 0.060 |
Why?
|
Ciprofloxacin | 1 | 2005 | 312 | 0.050 |
Why?
|
Image Enhancement | 1 | 2014 | 2885 | 0.050 |
Why?
|
Disease-Free Survival | 4 | 2017 | 6814 | 0.050 |
Why?
|
Suture Techniques | 1 | 2008 | 769 | 0.050 |
Why?
|
Hospital Mortality | 6 | 2013 | 5294 | 0.050 |
Why?
|
Peer Review, Research | 2 | 2016 | 340 | 0.050 |
Why?
|
Laparoscopy | 1 | 2015 | 2035 | 0.050 |
Why?
|
Hospitals | 1 | 2016 | 3882 | 0.050 |
Why?
|
Carotid Artery, Common | 1 | 2023 | 175 | 0.050 |
Why?
|
Upper Extremity | 1 | 2007 | 657 | 0.050 |
Why?
|
Mesenteric Artery, Superior | 1 | 2002 | 96 | 0.050 |
Why?
|
Hematoma | 2 | 2014 | 768 | 0.050 |
Why?
|
Follow-Up Studies | 10 | 2013 | 39106 | 0.050 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2009 | 1725 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5336 | 0.050 |
Why?
|
Asymptomatic Diseases | 2 | 2016 | 588 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 1996 | 5796 | 0.050 |
Why?
|
Heart Failure | 2 | 2005 | 11669 | 0.050 |
Why?
|
Blood Transfusion | 1 | 2008 | 1298 | 0.050 |
Why?
|
New England | 2 | 2016 | 1054 | 0.050 |
Why?
|
Incidence | 6 | 2016 | 21353 | 0.050 |
Why?
|
Myocardium | 1 | 2014 | 4726 | 0.050 |
Why?
|
Practice Guidelines as Topic | 3 | 2013 | 7390 | 0.050 |
Why?
|
Clavicle | 1 | 2023 | 224 | 0.050 |
Why?
|
Aneurysm | 1 | 2004 | 337 | 0.050 |
Why?
|
Myocardial Revascularization | 1 | 2005 | 790 | 0.050 |
Why?
|
Endarterectomy | 2 | 2013 | 196 | 0.050 |
Why?
|
Emergency Medical Services | 2 | 2009 | 1923 | 0.040 |
Why?
|
Age Factors | 5 | 2016 | 18395 | 0.040 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 1999 | 748 | 0.040 |
Why?
|
Overweight | 1 | 2010 | 2417 | 0.040 |
Why?
|
Osteotomy | 1 | 2024 | 837 | 0.040 |
Why?
|
Inpatients | 1 | 2010 | 2548 | 0.040 |
Why?
|
Decision Making | 1 | 2012 | 3929 | 0.040 |
Why?
|
Extremities | 1 | 2004 | 867 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2009 | 10209 | 0.040 |
Why?
|
Interferon-gamma | 2 | 1999 | 3162 | 0.040 |
Why?
|
Sex Factors | 4 | 2013 | 10552 | 0.040 |
Why?
|
Patient Care Team | 1 | 2009 | 2521 | 0.040 |
Why?
|
Morbidity | 1 | 2003 | 1750 | 0.040 |
Why?
|
Health Care Costs | 1 | 2011 | 3242 | 0.040 |
Why?
|
Anti-Infective Agents | 1 | 2005 | 983 | 0.040 |
Why?
|
Survival Analysis | 5 | 2013 | 10090 | 0.040 |
Why?
|
Prospective Studies | 7 | 2023 | 54425 | 0.040 |
Why?
|
Life Tables | 1 | 2017 | 364 | 0.030 |
Why?
|
Radiation Monitoring | 1 | 2017 | 103 | 0.030 |
Why?
|
Heart Valve Prosthesis | 1 | 2005 | 1462 | 0.030 |
Why?
|
Immunohistochemistry | 4 | 1999 | 11076 | 0.030 |
Why?
|
Cloning, Molecular | 3 | 1999 | 4174 | 0.030 |
Why?
|
Consensus | 2 | 2016 | 3123 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2017 | 3415 | 0.030 |
Why?
|
Obesity | 2 | 2009 | 12947 | 0.030 |
Why?
|
Antigens, Nuclear | 1 | 1996 | 184 | 0.030 |
Why?
|
Patient Discharge | 3 | 2013 | 3443 | 0.030 |
Why?
|
Preoperative Care | 1 | 2005 | 2242 | 0.030 |
Why?
|
Captopril | 1 | 1996 | 265 | 0.030 |
Why?
|
Thrombolytic Therapy | 1 | 2024 | 2064 | 0.030 |
Why?
|
Periodicals as Topic | 2 | 2016 | 1463 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2005 | 2244 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2006 | 3826 | 0.030 |
Why?
|
Hemorrhage | 2 | 2019 | 3424 | 0.030 |
Why?
|
Hexuronic Acids | 1 | 2014 | 145 | 0.030 |
Why?
|
Glucuronic Acid | 1 | 2014 | 150 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 1996 | 629 | 0.030 |
Why?
|
alpha 1-Antitrypsin | 1 | 1995 | 167 | 0.030 |
Why?
|
Stroke Volume | 1 | 2007 | 5496 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1995 | 1058 | 0.030 |
Why?
|
Muscle Proteins | 1 | 1999 | 1154 | 0.030 |
Why?
|
Fluoroscopy | 1 | 2017 | 947 | 0.030 |
Why?
|
Texas | 1 | 2014 | 404 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2014 | 413 | 0.030 |
Why?
|
Creatine Kinase | 1 | 1995 | 685 | 0.030 |
Why?
|
Thrombosis | 2 | 2019 | 2942 | 0.030 |
Why?
|
Cohort Studies | 5 | 2012 | 41487 | 0.030 |
Why?
|
Administration, Topical | 1 | 2014 | 704 | 0.030 |
Why?
|
Staphylococcus epidermidis | 1 | 2013 | 123 | 0.030 |
Why?
|
Graft Survival | 3 | 2010 | 3819 | 0.030 |
Why?
|
Retinoblastoma | 1 | 1995 | 317 | 0.030 |
Why?
|
Aneurysm, False | 1 | 2014 | 255 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 1996 | 1900 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2024 | 2751 | 0.020 |
Why?
|
Prevalence | 1 | 2009 | 15732 | 0.020 |
Why?
|
Workload | 1 | 2017 | 844 | 0.020 |
Why?
|
DNA, Complementary | 1 | 1995 | 1991 | 0.020 |
Why?
|
Vascular System Injuries | 1 | 2014 | 246 | 0.020 |
Why?
|
Hospitals, University | 1 | 2013 | 563 | 0.020 |
Why?
|
Pain Measurement | 1 | 2021 | 3550 | 0.020 |
Why?
|
Recovery of Function | 1 | 2021 | 2979 | 0.020 |
Why?
|
Heart Diseases | 2 | 2004 | 2781 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2016 | 8002 | 0.020 |
Why?
|
Life Expectancy | 1 | 2017 | 1242 | 0.020 |
Why?
|
Aortography | 1 | 2012 | 421 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 1999 | 3492 | 0.020 |
Why?
|
Equipment Design | 1 | 2017 | 3510 | 0.020 |
Why?
|
Ankle Brachial Index | 1 | 2010 | 163 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20098 | 0.020 |
Why?
|
Gadolinium | 1 | 2014 | 960 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 931 | 0.020 |
Why?
|
Adolescent | 4 | 2024 | 88319 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2016 | 2115 | 0.020 |
Why?
|
Young Adult | 4 | 2024 | 59243 | 0.020 |
Why?
|
Electrocardiography | 2 | 2014 | 6377 | 0.020 |
Why?
|
American Heart Association | 1 | 2013 | 1039 | 0.020 |
Why?
|
Prognosis | 2 | 2006 | 29625 | 0.020 |
Why?
|
Embolectomy | 1 | 2009 | 129 | 0.020 |
Why?
|
Disease Progression | 2 | 2013 | 13506 | 0.020 |
Why?
|
Base Sequence | 2 | 1999 | 12441 | 0.020 |
Why?
|
Heart Arrest | 1 | 2018 | 1514 | 0.020 |
Why?
|
Adipokines | 1 | 2010 | 310 | 0.020 |
Why?
|
Device Removal | 1 | 2013 | 630 | 0.020 |
Why?
|
Molecular Weight | 1 | 2010 | 2186 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1505 | 0.020 |
Why?
|
Radiography | 2 | 2012 | 6965 | 0.020 |
Why?
|
RNA | 1 | 1997 | 2726 | 0.020 |
Why?
|
Risk | 1 | 1999 | 9610 | 0.020 |
Why?
|
Kidney | 1 | 2022 | 7048 | 0.020 |
Why?
|
History, 21st Century | 1 | 2013 | 1567 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2024 | 5440 | 0.020 |
Why?
|
Emergencies | 1 | 2013 | 1217 | 0.020 |
Why?
|
Animals | 6 | 2005 | 168459 | 0.020 |
Why?
|
ROC Curve | 1 | 2014 | 3579 | 0.020 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 698 | 0.020 |
Why?
|
Embolization, Therapeutic | 1 | 2016 | 1418 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 1995 | 6075 | 0.020 |
Why?
|
Rats | 2 | 2005 | 23742 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2012 | 21012 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2010 | 2115 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3808 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1996 | 8181 | 0.010 |
Why?
|
Probability | 1 | 2010 | 2477 | 0.010 |
Why?
|
Hospital Costs | 1 | 2010 | 947 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2010 | 2927 | 0.010 |
Why?
|
Algorithms | 1 | 2005 | 14031 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2009 | 1336 | 0.010 |
Why?
|
Ultrasonography, Doppler | 1 | 2006 | 462 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3249 | 0.010 |
Why?
|
Physical Examination | 1 | 2010 | 1255 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2850 | 0.010 |
Why?
|
Magnetic Resonance Angiography | 1 | 2010 | 1432 | 0.010 |
Why?
|
Communication | 1 | 2017 | 3873 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2013 | 2775 | 0.010 |
Why?
|
Los Angeles | 1 | 2002 | 243 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10766 | 0.010 |
Why?
|
Materials Testing | 1 | 2005 | 863 | 0.010 |
Why?
|
Postoperative Period | 1 | 2006 | 1813 | 0.010 |
Why?
|
Rats, Wistar | 1 | 2005 | 1848 | 0.010 |
Why?
|
Endocarditis, Bacterial | 1 | 2005 | 436 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8529 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 1995 | 7594 | 0.010 |
Why?
|
Contrast Media | 1 | 2014 | 5311 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 2007 | 1165 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8830 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2003 | 12148 | 0.010 |
Why?
|
Population Surveillance | 1 | 2009 | 2598 | 0.010 |
Why?
|
Models, Animal | 1 | 2005 | 2112 | 0.010 |
Why?
|
Transforming Growth Factor alpha | 1 | 1999 | 135 | 0.010 |
Why?
|
Reference Values | 1 | 2006 | 4920 | 0.010 |
Why?
|
Ischemic Attack, Transient | 1 | 2003 | 882 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 1999 | 255 | 0.010 |
Why?
|
DNA Probes | 1 | 1998 | 541 | 0.010 |
Why?
|
Mortality | 1 | 2009 | 2901 | 0.010 |
Why?
|
Mitral Valve | 1 | 2005 | 1465 | 0.010 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 1999 | 592 | 0.010 |
Why?
|
Ultrasonography | 1 | 2010 | 5972 | 0.010 |
Why?
|
Platelet-Derived Growth Factor | 1 | 1999 | 618 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 1999 | 17635 | 0.010 |
Why?
|
Forecasting | 1 | 2005 | 2928 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2010 | 14666 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2010 | 14605 | 0.010 |
Why?
|
Graft Rejection | 1 | 2006 | 4445 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 1999 | 1320 | 0.010 |
Why?
|
Pneumonia | 1 | 2004 | 2143 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2006 | 12341 | 0.010 |
Why?
|
Blotting, Western | 1 | 1999 | 5035 | 0.010 |
Why?
|
Up-Regulation | 1 | 1999 | 4124 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20570 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1999 | 18965 | 0.000 |
Why?
|